InsidersTradesSigma
Follow the Dicot Pharma AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Market capitalisation: €710.4m. The latest transaction was reported on 6 June 2026 (Purchase). Among the most active insiders: Per-Göran Gillberg. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Dicot Pharma AB is a Swedish pharmaceutical company focused on developing innovative treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange.